(Q34485701)

2 August 2017

1 reference

title

Lung disease in primary antibody deficiency (English)

1 reference

2 August 2017

1 reference

1 reference

2

Bodo Grimbacher

1 reference

2 August 2017

Nisha Verma

1

1 reference

2 August 2017

John R Hurst

series ordinal

3

1 reference

2 August 2017

publication date

15 July 2015

1 reference

The Lancet. Respiratory medicine

2 August 2017

published in

1 reference

2 August 2017

volume

3

1 reference

2 August 2017

issue

8

1 reference

2 August 2017

page(s)

651-660

1 reference

Screening of Canadian Blood Services donors for severe immunoglobulin A deficiency.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

The European internet-based patient and research database for primary immunodeficiencies: results 2004-06.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

X-Linked Agammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Autosomal recessive agammaglobulinemia: the third case of Igβ deficiency due to a novel non-sense mutation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Clinical, immunological, and molecular characterization of hyper-IgM syndrome due to CD40 deficiency in eleven patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Perspectives on common variable immune deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Clinical symptoms in adults with selective IgA deficiency: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

What is Good's syndrome? Immunological abnormalities in patients with thymoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Identification of variations in the human phosphoinositide 3-kinase p110delta gene in children with primary B-cell immunodeficiency of unknown aetiology

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase δ syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Pulmonary radiologic findings in common variable immunodeficiency: clinical and immunological correlations

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Activity, severity and impact of respiratory disease in primary antibody deficiency syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Morbidity and mortality in common variable immune deficiency over 4 decades

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

CT screening for pulmonary pathology in common variable immunodeficiency disorders and the correlation with clinical and immunological parameters

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

High resolution computed tomography and pulmonary function in common variable immunodeficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Common variable immunodeficiency: association between memory B cells and lung diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Lung MRI as a possible alternative to CT scan for patients with primary immune deficiencies and increased radiosensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Longitudinal decline in lung function in patients with primary immunoglobulin deficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Serial lung function tests in primary immune deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Economic impact of infections among patients with primary immunodeficiency disease receiving IVIG therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Effectiveness of Immunoglobulin Replacement Therapy on Clinical Outcome in Patients with Primary Antibody Deficiencies: Results from a Multicenter Prospective Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Incidence of infection is inversely related to steady-state (trough) serum IgG level in studies of subcutaneous IgG in PIDD

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Cytomegalovirus disease in patients with common variable immunodeficiency: three case reports

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

British Thoracic Society guideline for non-CF bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

National BTS bronchiectasis audit 2012: is the quality standard being adhered to in adult secondary care?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Clinical picture and treatment of 2212 patients with common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Respiratory disease in common variable immunodeficiency and other primary immunodeficiency disorders

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Association of FcRn expression with lung abnormalities and IVIG catabolism in patients with common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Antibiotic prophylaxis in primary immune deficiency disorders

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Microbial dysbiosis in bronchiectasis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

The HRCT appearances of granulomatous pulmonary disease in common variable immune deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Tertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Inflammation in common variable immunodeficiency is associated with a distinct CD8(+) response to cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Granulomatosis-associated common variable immunodeficiency disorder: a case-control study versus sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Bronchoalveolar lavage cytology resembles sarcoidosis in a subgroup of granulomatous CVID

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Bronchoalveolar lavage cytology resembles sarcoidosis in a subgroup of granulomatous CVID

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Lung disease, T-cells and inflammation in common variable immunodeficiency disorders

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Common variable hypogammaglobulinemia with T-cell nodular lymphoid interstitial pneumonitis and B-cell nodular lymphoid hyperplasia: different lymphocyte populations with a similar response to prednisone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Lymphoid interstitial pneumonitis associated with common variable hypogammaglobulinaemia treated with cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Common variable immune deficiency and lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Bronchiolitis Obliterans Organizing Pneumonia in Common Variable Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

Pulmonary mucosa-associated lymphoid tissue lymphoma in a patient with common variable immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900202-7

7 January 2021

10.1016/S2213-2600(15)00202-7

Identifiers

DOI

1 reference

2 August 2017

1 reference